Literature DB >> 1079022

Mechanisms of radio-protection by catecholamines in the hamster (Mesocricetus auratus).

R L Prewitt, X J Musacchia.   

Abstract

Whole-body exposure to 1000 or 2000 rads in a 60Co source was used to study radio-protection by norepinephrine, isoproterenol, and phenylephrine in normal and splenectomized hamsters. After exposure, the animals were caged individually, and percent survivals were recorded daily. The aortic blood pressure of permanently cannulated, unanaesthetized hamsters was measured to test the vasoconstriction-hypoxia mechanism of radio-protection, and plasma calcium levels were measured to test the hypothesis that isoproterenol protects through a mechanism of hypercalcaemia-stimualted cell proliferation. The data support the vasoconstriction-hypoxia mechanism for agents stimulating the alpha receptors, while beta agonists seem to protect through a hypotensive-hypoxia mechanism similar to that of histamine. All the catecholamines protect against the haematopoietic syndrome, but show no evidence of protection against the gastrointestinal syndrome.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1079022     DOI: 10.1080/09553007514550181

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  3 in total

Review 1.  Comparative efficacy and the window of radioprotection for adrenergic and serotoninergic agents and aminothiols in experiments with small and large animals.

Authors:  Mikhail V Vasin; Igor B Ushakov
Journal:  J Radiat Res       Date:  2014-10-13       Impact factor: 2.724

Review 2.  Comments on the mechanisms of action of radiation protective agents: basis components and their polyvalence.

Authors:  Mikhail V Vasin
Journal:  Springerplus       Date:  2014-08-07

3.  Protective Effects of 2-Amino-5,6-dihydro-4H-1,3-thiazine and Its Derivative against Radiation-Induced Hematopoietic and Intestinal Injury in Mice.

Authors:  Yuanyuan Li; Shaofan Kong; Fujun Yang; Wenqing Xu
Journal:  Int J Mol Sci       Date:  2018-05-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.